Peptide Inhibitors

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
CAT# Product Name M.W Molecular Formula Inquiry
R2526 N-(3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)propanoyl)-O-(tert-butyl)-L-serine 454.5 C25H30N2O6
R2527 N-(3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)propanoyl)-O-(tert-butyl)-L-threonine 468.5 C26H32N2O6
R2528 Fmoc--Ala-Val-OH 410.5 C23H26N2O5
R2529 E9CY63Z7ZB 582.6 C31H38N2O9
R2530 Fmoc-leu-leu-OH 466.6 C27H34N2O5
R2531 Phoenixin-20 2181.4 C101H153N25O29
R2532 Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(phenylmethyl)- 244.29 C14H16N2O2
R2533 Boc-Glu-Lys-Lys-AMC 660.8 C32H48N6O9
R2534 N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-delta-t-butyloxycarbonyl-N-delta-i-propyl-L-ornithine 496.6 C28H36N2O6
R2535 Octa(OtBu)-Glu-OtBu 555.8 C31H57NO7
R2536 Ntfapi 771.8 C36H47F2N9O8
R2537 Pegcetacoplan acetate (C2H4O)nC170H248N50O47S4.xC2H4O2
R2538 H-Gly-Arg-Gly-Asp-Tyr-Ile-Trp-Ser-Leu-Asp-Thr-Gln-OH 1410.5 C62H91N17O21
R2539 Satoreotide Tetraxetan 1689.3 C74H98ClN19O21S2
R2540 H-Tyr-Ala-Pro-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH 4952 C226H338N60O64S
R2541 Mca-SEVNLDAEFK(Dnp)-NH2 1532.5 C68H89N15O26
R2542 H-Thr-pro-asp-ile-asn-pro-ala-trp-tyr-thr-gly-arg-gly-ile-arg-pro-val-gly-arg-phe-NH2 2272.6 C104H158N32O26
R2543 N-acetyl lysyltyrosylcysteine amide 453.6 C20H31N5O5S
R2544 Glu-Phe 294.3 C14H18N2O5
R2545 N-(3,3-Dimethylbutyl)-L-alpha-aspartyl-L-phenylalanine 364.4 C19H28N2O5